Imeik Technology Development Co.,Ltd. (SHE:300896)

Market Cap	54.92B
Revenue (ttm)	2.67B
Net Income (ttm)	1.63B
Shares Out	301.43M
EPS (ttm)	5.40
PE Ratio	33.74
Forward PE	29.96
Dividend	3.80 (2.09%)
Ex-Dividend Date	Sep 26, 2025

Volume	2,488,991
Average Volume	3,791,214
Open	181.28
Previous Close	182.21
Day's Range	177.70 - 182.50
52-Week Range	147.00 - 282.72
Beta	1.33
RSI	42.25
Earnings Date	Oct 24, 2025

About SHE:300896

Imeik Technology Development Co.,Ltd. engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China. It offers aesthetic medicine products, including cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere, poly facial implant thread, medical sodium hyaluronate-hydroxypropyl methylcellulose gel, sodium hyaluronate composite solution for injection, modified sodium hyaluronate gel for injection, and medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel. The ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 1,223
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300896

Financial Performance

In 2024, SHE:300896's revenue was 3.03 billion, an increase of 5.45% compared to the previous year's 2.87 billion. Earnings were 1.96 billion, an increase of 5.33%.